United Therapeutics (UTHR) Times Interest Earned (2009 - 2026)

United Therapeutics (UTHR) has 18 years of Times Interest Earned data on file, last reported at $0.18 in Q1 2026.

• For the quarter ending Q1 2026, Times Interest Earned fell 58.34% year-over-year to $0.18; the trailing twelve-month figure through Mar 2026 stood at $0.81 (down 49.93% YoY), and the FY2025 full-year result was $76.54, up 138.45% from the prior year.
• Times Interest Earned eased to $0.18 in Q1 2026, from $115.06 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $115.06 in Q4 2025 to a low of $0.18 in Q1 2026.
• A 5-year average of $13.01 and a median of $0.54 in 2022 frame the typical range for Times Interest Earned.
• Peak annual rise in Times Interest Earned reached 461.47% in 2022, while the deepest fall reached 60.48% in 2022.
• Tracing UTHR's Times Interest Earned over 5 years: stood at $14.28 in 2022, then climbed by 20.65% to $17.23 in 2023, then surged by 299.35% to $68.79 in 2024, then jumped by 67.27% to $115.06 in 2025, then sank by 99.84% to $0.18 in 2026.
• Business Quant data shows UTHR's Times Interest Earned at $0.18 in Q1 2026, $115.06 in Q4 2025, and $0.28 in Q3 2025.